1.21
Schlusskurs vom Vortag:
$1.20
Offen:
$1.2
24-Stunden-Volumen:
499.67K
Relative Volume:
0.43
Marktkapitalisierung:
$166.05M
Einnahmen:
$4.35M
Nettoeinkommen (Verlust:
$-45.53M
KGV:
-1.1204
EPS:
-1.08
Netto-Cashflow:
$-44.79M
1W Leistung:
-5.47%
1M Leistung:
+19.80%
6M Leistung:
-3.20%
1J Leistung:
+24.87%
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LUCD
Lucid Diagnostics Inc
|
1.21 | 122.27M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
Is Lucid Diagnostics Inc. meeting your algorithmic filter criteriaQuarterly Portfolio Summary & Daily Chart Pattern Signals - newser.com
Live market analysis of Lucid Diagnostics Inc.Stock Surge & AI Forecasted Entry/Exit Points - newser.com
Is Lucid Diagnostics Inc. stock ready for a breakoutJobs Report & Expert Curated Trade Setups - newser.com
Is Lucid Diagnostics Inc. stock supported by innovation pipelineJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com
Measuring Lucid Diagnostics Inc.’s beta against major indicesJuly 2025 Outlook & AI Optimized Trade Strategies - newser.com
Is Lucid Diagnostics Inc. stock oversold or undervalued2025 Sector Review & Risk Adjusted Buy/Sell Alerts - newser.com
Will Lucid Diagnostics Inc. stock maintain momentum in 2025Earnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Combining machine learning predictions for Lucid Diagnostics Inc.Weekly Trade Analysis & Verified Trade Idea Suggestions - newser.com
Can Lucid Diagnostics Inc. stock sustain revenue growthWeekly Risk Report & Verified Entry Point Signals - newser.com
How Lucid Diagnostics Inc. stock reacts to oil pricesJuly 2025 Patterns & Weekly High Momentum Picks - newser.com
Will Lucid Diagnostics Inc. stock continue dividend increasesRate Cut & Fast Exit and Entry Trade Guides - newser.com
Why retail investors favor Lucid Diagnostics Inc. stockBuy Signal & Low Drawdown Trading Strategies - newser.com
Lucid Diagnostics Inc. (LUCD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 - Eastern Progress
PAVmed (NASDAQ: PAVM) schedules Nov 13 webcast at 8:30 AM ET on third-quarter results - Stock Titan
Lucid Diagnostics Inc. (LUCD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lucid Diagnostics (NASDAQ: LUCD) to host webcast on Q3 2025 results update - Stock Titan
Can Lucid Diagnostics Inc. stock surprise with earnings upsideJuly 2025 Setups & Risk Controlled Swing Trade Alerts - fcp.pa.gov.br
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):